Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

NCT00005812 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped No objective response documented, protocol terminated after 12 patients.

Conditions

Brain Tumors
Central Nervous System Tumors
Leptomeningeal Metastases

Interventions

DRUG: temozolomide

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]